Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0
NCT ID: NCT02075398
Last Updated: 2014-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2013-12-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiration Rate V2.0 in Healthy Volunteers
NCT01804062
Respiration Rate V2.0 in a Hospital Setting
NCT01837537
Nellcorâ„¢ Investigational Device Sitting-Walking Study
NCT07234279
Pulse Oximetry- Evaluating Resp Rate- PCBA-1
NCT01791582
Novel Non-Invasive Monitoring Parameter in Healthy Volunteers
NCT01294514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is able to participate for the duration of the study
* Subject is willing to sign an informed consent
Exclusion Criteria
* Physiologic abnormalities that prevent proper application of pulse oximetry sensor
* Severe contact allergies that cause a reaction to standard adhesive materials such as those fund in medical sensors and electrodes
* Subjects with significant arrhythmia, as determined by subject self-report during screening and I/E criteria assessment at study start. (Three events of irregularities in radial pulse with thirty seconds).
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic - MITG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelley Scott, MD
Role: PRINCIPAL_INVESTIGATOR
Medtronic - MITG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boulder Clinical Laboratory
Boulder, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVMOPR0428
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.